HELPING THE OTHERS REALIZE THE ADVANTAGES OF ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

More studies in progress advise that ARV-825 may additionally be effective in improving the reaction to estrogen deprivation (aromatase inhibition), another part of standard of care in ER+ breast cancer.- "Our study uncovered the critical position on the KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA,